PYRALVEX

This brand name is authorized in Ecuador, Spain, France, Singapore, United Kingdom

Active ingredients

The drug PYRALVEX contains a combination of these active pharmaceutical ingredients (APIs):

1 Salicylic acid UNII O414PZ4LPZ - SALICYLIC ACID

Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. Read about Salicylic acid

2 Extractum rhei UNII YM64C2P6UX - RHEIN

Read about Anthraquinone glycosides

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A01AD	Other agents for local oral treatment	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations
Discover more medicines within A01AD
A01AD05	Acetylsalicylic acid	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 360670612
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 24135, 2931-18-1-05, 2931-18-1-05IP
Country: FR	Base de données publique des médicaments	Identifier(s): 63378561, 63938387
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 39891
Country: SG	Health Sciences Authority	Identifier(s): 04226P